19 May 2013
Keywords: gsk, bi, license, sa, thembalami, make, arvs
Article | 19 July 2004
South Africa's Thembalami has been licensed by European drug majorsGlaxoSmithKline and Boehringer Ingelheim to make and sell generic
antiretroviral drugs ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 July 2004
17 May 2013
© 2013 thepharmaletter.com